COMPANY INFO
Truveta, Inc. was founded in 2020 as a collaboration among Providence, Advocate Aurora Health, Tenet Health, and Trinity Health. The company was co-founded by Terry Myerson (CEO), Jay Nanduri (CTO), and Dr. Ryan Ahern (Chief Medical Officer). It has approximately 333 employees and operates in the healthcare software and data analytics industry. Truveta's mission is to save lives with data by providing a healthcare data platform that connects data, people, and ideas to improve patient care, support life science research, and enable medical AI training. The company is headquartered in the Seattle area, Washington, and its website is https://www.truveta.com.
Truveta is a healthcare software and data analytics company founded in 2020 as a collaboration among major healthcare systems including Providence, Advocate Aurora Health, Tenet Health, and Trinity Health. Headquartered in Bellevue, Washington, Truveta is on a mission to save lives with data by providing a powerful healthcare data platform that connects data, people, and ideas to enhance patient care, support life science research, and enable advanced medical AI training. Led by co-founders Terry Myerson, Jay Nanduri, and Dr. Ryan Ahern, the company employs over 340 people and operates at the intersection of health data, analytics, and enterprise healthcare systems.
Truveta funding has fueled the company’s rapid growth and ambitious projects. Since its inception, Truveta has raised a total of $515 million across four funding rounds, featuring a mix of strategic health systems, life science companies, and leading venture capital backers. Notable milestones include its Series C round, which valued the company at $1 billion. The company’s funding history reflects a deliberate strategy of partnering with both the healthcare ecosystem and technology leaders to accelerate the development of one of the world’s largest health data and genomic platforms, supporting both innovation in care and research.
This Series C round was aimed at sequencing 10 million exomes to build the world's largest genetic database, supporting drug discovery, clinical trials, and personalized healthcare via advanced AI and cloud infrastructure.
The Series B round supported the continued growth and expansion of Truveta's integrated health data platform as it brought on more partners and scaled its operations to serve a broader healthcare and life sciences audience.
This tranche of Series A funding was led by Microsoft to accelerate Truveta’s product development and platform capabilities.
The initial Series A round was used to enhance Truveta's health data platform and bring additional health system members into its collaborative network.
As a technology leader, Microsoft played a pivotal role as a lead investor in Truveta’s Series A funding, facilitating the company’s platform acceleration and AI-driven initiatives.
Illumina, a global genomics leader, participated as a strategic investor in Truveta’s Series C round, supporting efforts to build one of the world’s largest genomic and health data repositories.
Regeneron Pharmaceuticals brought their expertise in genetics and drug development to the Series C funding, aiming to further integrate genomics data for research and discovery.
One of Truveta’s founding partners and a recurring key investor, Providence has continuously supported the company’s mission to transform healthcare with data.
Trinity Health, another founding consortium member and Series C investor, enabled Truveta's expansion into broader health data integration and research settings.
Northwell joined as a health system investor during the Series C round, facilitating access to extensive clinical care data and research partnerships.
With investment in the Series C round, CommonSpirit accelerated Truveta's outreach to diverse health system data and fostered collaborative care innovation.
A longstanding partner, Advocate Health participated in Truveta’s Series C, advancing the connection of multi-state clinical data for research and AI.
As part of the Series C, Henry Ford Health System expanded the reach and representativeness of Truveta’s platform with vital health system data and insights.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Truveta funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.